Clinical trials
Tuberculosis (TB) clinical trials
Below are recruiting tuberculosis (tb) clinical trials, each written for real people, not researchers. We’re tracking 60 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07164742Recruiting
Recovery help for lung health after TB treatment
This study tests whether a lung rehabilitation program (like physical therapy for your lungs) can help people who recently started TB treatment breathe and feel better. You need a smartphone and must be willing to attend sessions for 48 weeks.
MangaloreAges 18 years+ - NCT07312266Recruiting
Questioning asymptomatic TB in HIV patients
This study looks for tuberculosis (TB) in people with HIV who have no symptoms. It aims to understand how common hidden TB is, which could lead to better detection and prevention.
Manhiça, Maputo ProvinceAges 18 years+ - NCT06314386Enrolling by invitation
Improving TB prevention in Eastern Cape clinics
This study looks at how to improve TB prevention in rural and semi-urban clinics in South Africa. They will work with clinic staff and district leaders to find better ways to stop TB.
AddoAges birth+ - NCT06221488Recruiting
TB testing for health workers at risk
This study tests health workers for tuberculosis (TB) infection to better understand who is at risk. It may help find ways to protect health workers from TB.
Cape TownAges 18–100 - NCT06476210RecruitingPhase 4
New drug combo for drug-resistant tuberculosis
This trial tests a three-drug combination (bedaquiline, delamanid, and linezolid) to see if it's safe and works well for people with multi-drug resistant or rifampicin-resistant tuberculosis. It may offer a new treatment option if standard drugs aren't working.
Hefei, AnhuiAges 18 years+ - NCT05081401RecruitingPhase 3
All-oral shorter treatment for rifampicin-resistant TB
This Phase 3 trial tests a shorter, all-pill (oral) treatment plan for people with rifampicin-resistant pulmonary tuberculosis. It aims to improve treatment while reducing the burden of therapy, using a plan tailored to the individual.
Guiyang, GuizhouAges 16–75 - NCT04700579Recruiting
Study lung changes before and after treatment for active TB
This study looks at changes in the lungs and immune system before TB treatment and again after treatment. By sampling lung fluid and comparing it over time, researchers hope to learn signatures that reflect how TB responds to care.
Cape Town, Western CapeAges 18–60 - NCT06909799Recruiting
NAC to prevent lung damage after TB treatment
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
Fajara, The GambiaAges 18–65 - NCT06253715RecruitingPhase 3
Shorter TB treatment for children
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
ChennaiAges birth–9 years - NCT07178860Recruiting
Lung health after TB treatment study
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
LiverpoolAges 18 years+ - NCT02354014RecruitingPhase 2
Test drug levels and TB activity of TMC207 in children
This study measures how TMC207 (an anti-TB medicine) works in the body and in combination with standard MDR-TB medicines for children and teens with lung MDR-TB. It may help clinicians learn the safest way to use TMC207 and how well it may support treatment.
MaputoAges birth–18 years - NCT06764576Recruiting
Study for people with suspected tuberculosis or related infections
This trial is looking for adults who might have tuberculosis, a related infection called non-tubercular mycobacteriosis, or a hidden (latent) tuberculosis infection. You will provide a sample for testing, and the study will help doctors understand and manage these infections better.
BolognaAges 18 years+ - NCT06272812RecruitingPhase 2
TB vaccine study for teens and adults
This trial tests whether a new vaccine called MTBVAC can prevent tuberculosis (TB) in people living in areas where TB is common. If you are between 14 and 45 years old and in good health, you may be able to join.
KisumuAges 14–45 - NCT06022146RecruitingPhase 3
Short TB prevention for school contacts
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
Anshun, GuiyangAges 13 years+ - NCT06702774Recruiting
TB control study for high-risk groups in Guangxi
This study tests new ways to control the spread of tuberculosis (TB) in high-risk areas of Guangxi, China. It focuses on older adults and people with conditions that make them more likely to get TB.
Nanning, GuangxiAges 15 years+ - NCT06796647Recruiting
TB skin test for patients with rheumatologic conditions
This trial is testing a new type of skin test (called ESAT6/CFP10) to check for TB infection in people who have a rheumatologic disease and are about to start certain medications (b/tsDMARDs). The goal is to see if this skin test works well for these patients.
Hong Kong, Hong KongAges 18–65 - NCT06916962Recruiting
Supporting TB recovery: The UPLIFT trial
This trial is studying if offering extra support to people being treated for tuberculosis (TB) can help them recover and feel better overall. It's for people who have started treatment for drug-sensitive TB and live in certain areas.
Ba Ria Vung TauAges 18 years+ - NCT06706596Recruiting
TB screening for high-risk groups in Barcelona
This trial offers free tuberculosis (TB) testing for people who are at high risk for the disease. It aims to find TB early so it can be treated quickly.
BadalonaAges Any age - NCT06700876Recruiting
TB test study for kidney disease or transplant patients
This study looks at better ways to find hidden (subclinical) tuberculosis (TB) in people with serious kidney disease or those who have had a kidney transplant. If you have kidney failure on dialysis or have a kidney transplant, you may qualify and help improve TB detection.
BangkokAges 18 years+ - NCT07119359Recruiting
TB and HIV prevention study for households in Uganda
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
KampalaAges 15 years+ - NCT07227779RecruitingPhase 2
B-PaLMZ for TB meningitis in people with HIV
This trial tests a combination of TB medicines (B-PaLMZ) for people with HIV who have their first episode of TB meningitis. It aims to find a better treatment option.
KampalaAges 18 years+ - NCT06971952Recruiting
Tuberculosis study in rural malnourished communities
This study looks at how TB affects people in rural areas who may also be malnourished. It aims to understand and improve TB care for these communities.
Haydom, Manyara RegionAges Any age - NCT07024836Recruiting
Precision biomarker-guided management of TB contacts
This study looks at how to best manage latent tuberculosis (TB) infection using a test that finds people at risk. It aims to help doctors and patients make better decisions together.
LondonAges 18 years+ - NCT05655702Recruiting
Drug use and infections study for tuberculosis control in Vietnam
This study looks at how injecting drug use is linked with infections, including tuberculosis, and aims to improve TB control. You may be asked to share information and provide tests related to recent drug use and injection sites.
HaiphongAges 18 years+
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tuberculosis (tb)?
- Yes. Clin2 currently lists 60 recruiting tuberculosis (tb) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tuberculosis (tb) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tuberculosis (tb) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.